| RS1554649344 |
TG
|
Health Risk |
Pathogenic |
Iodotyrosyl coupling defect, Iodotyrosyl coupling defect |
| RS1554649366 |
NFIB
|
Health Risk |
Pathogenic |
Macrocephaly, Intellectual disability |
| RS1554649675 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1554651153 |
RMRP
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651349 |
RMRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1554651360 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1554651364 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1554651365 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651368 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651373 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651375 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1554651376 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Anauxetic dysplasia, Metaphyseal chondrodysplasia |
| RS1554651379 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1554651381 |
RMRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651382 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651385 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1554651387 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1554651395 |
RMRP
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651396 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651397 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651399 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1554651400 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal dysplasia without hypotrichosis, Metaphyseal chondrodysplasia |
| RS1554651403 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651404 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651405 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651411 |
RMRP
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651413 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651414 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1554651418 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651422 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651423 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Metaphyseal chondrodysplasia |
| RS1554651424 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651425 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651427 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651428 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651430 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1554651439 |
RMRP
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651445 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Anauxetic dysplasia, Metaphyseal chondrodysplasia |
| RS1554651446 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651447 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651451 |
RMRP
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651453 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651455 |
RMRP
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651461 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651462 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651464 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1554651466 |
RMRP
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651469 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal dysplasia without hypotrichosis, Metaphyseal chondrodysplasia |
| RS1554651471 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651473 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651479 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1554651481 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651486 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651489 |
RMRP
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651491 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651499 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651503 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651505 |
RMRP
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651506 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651507 |
RMRP
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651508 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Metaphyseal chondrodysplasia |
| RS1554651512 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651513 |
RMRP
|
Health Risk |
Pathogenic/Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651524 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651526 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651532 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651537 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1554651543 |
RMRP
|
Health Risk |
Pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651544 |
RMRP
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1554651552 |
RMRP
|
Health Risk |
Pathogenic |
Anauxetic dysplasia, Anauxetic dysplasia |
| RS1554652265 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS1554652528 |
CYP11B1
|
Health Risk |
Pathogenic |
Deficiency of steroid 11-beta-monooxygenase, CYP11B1-related disorder |
| RS1554652650 |
CYP11B1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS1554652870 |
GLDC
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy 1 |
| RS1554652990 |
CYP11B1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS1554652998 |
CYP11B1
|
Health Risk |
Pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS1554652999 |
CYP11B1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Glucocorticoid-remediable aldosteronism |
| RS1554653185 |
CYP11B1
|
Health Risk |
Pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS1554653291 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Melanoma-pancreatic cancer syndrome, Melanoma-pancreatic cancer syndrome |
| RS1554653514 |
CYP11B1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS1554653520 |
CYP11B1
|
Health Risk |
Pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS1554653551 |
CYP11B1
|
Health Risk |
Likely pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS1554653675 |
CYP11B1
|
Health Risk |
Pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS1554653714 |
CYP11B1
|
Health Risk |
Pathogenic |
Deficiency of steroid 11-beta-monooxygenase, Deficiency of steroid 11-beta-monooxygenase |
| RS1554653915 |
CDKN2A
|
Health Risk |
Likely pathogenic |
Familial melanoma, Familial melanoma |
| RS1554653922 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Squamous cell carcinoma of the head and neck |
| RS1554653956 |
CDKN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1554653976 |
CDKN2A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1554654024 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS1554654044 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1554654052 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS1554654224 |
CDKN2A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS1554655653 |
DOCK8
|
Health Risk |
Likely pathogenic |
— |
| RS1554656253 |
CDKN2A
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS1554656266 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1554656288 |
EXT1
|
Health Risk |
Pathogenic |
Multiple congenital exostosis, Multiple congenital exostosis |
| RS1554656382 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |
| RS1554656411 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Hereditary cancer-predisposing syndrome |
| RS1554656624 |
CDKN2A
|
Health Risk |
Pathogenic |
Familial melanoma, Familial melanoma |
| RS1554656670 |
CDKN2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial melanoma |